The pharmaceutical industry in some ways can be seen as rather cyclical. New diseases are discovered, new cures are discovered, the cures are patented, the drugs are sold, the profits go up, the patents expire, the generics come forth, the profits die down. The cycle...
Merck & Co. Inc, 2018 Stock Rationale.
Jan 30, 2018 | Pharma
At the end of 2017 I published a list of companies that I expect will perform great in 2018. As a follow-up to that list I will publish my findings and due diligence for the individual asset selection. If there are any revisions to the list they will be accessible on...
3 Pharma Stock Picks for December
Dec 10, 2017 | Pharma, Research
In the midst of endless bitcoin drama, upcoming launch of CME BTC futures, and the holiday season, it's been very difficult for many investors to stay on track. Many investors opt for seasonal stocks that should fluctuate within the next couple of months until the...
Why Investors Need to Re-examine the U.S. and European Pharmaceutical Industry
Sep 26, 2017 | Economics, Pharma, Research
The pharmaceutical industry is one of the strongest elements of the financial world, known mainly for its undying demand and extremely high barriers of entry. It also remains an industry that tends to often come under fire from the general public for not subjecting...